Foundation Fighting Blindness: Translational Research Acceleration Program for Sight-Saving Therapies

The Foundation Fighting Blindness has launched a new Translational Research Acceleration Program (TRAP) to help advance vision-saving research into clinical trials.

To that end, the foundation welcomes proposals for retinal degeneration treatment approaches, including but not limited to gene therapies, regenerative treatments, and novel medical therapies, and has created a variety of TRAP grant mechanisms through which it can provide up to $1.5 million in funding over the next three years.

TRAP brings a proactive program management structure and hands-on advisory committee with expertise in drug development, clinical trials, business and commercialization, regulatory guidance, intellectual property, and partnerships catalyzing the movement of technology into clinical use to the evaluation of proposals.

A Proposer’s Day event will be held on August 3 at 1:00 p.m. ET via ZOOM to review program details and answer questions. (Registration required.)

For additional information and/or to apply for a grant, visit the Foundation Fighting Blindness.